 | • レポートコード：MRC2Q12-17058 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、骨吸収阻害剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 骨吸収阻害剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 骨吸収阻害剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 骨吸収阻害剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの骨吸収阻害剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の骨吸収阻害剤の売上および2028年までの予測に焦点を当てています。 骨吸収阻害剤のグローバル主要企業には、Novartis、Pfizer、Amgen、Apotex、Athenex Pharmaceuticl Divison、BPI Labs、Cipla USA、Merck、Mylan Institutional、Sagent Pharmaceuticals、Accord Healthcare、Fresenius Kabi、Dr. Reddy's Laboratories、Viatris、Hikma Pharmaceuticals、Aurobindo Pharma、Akorn、Teva Pharmaceuticals、Sun Pharma、Sun Pharmaceutical Industriesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 骨吸収阻害剤市場は、タイプとアプリケーションによって区分されます。世界の骨吸収阻害剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 経口、非経口 【アプリケーション別セグメント】 骨巨細胞腫、高カルシウム血症、骨粗鬆症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 骨吸収阻害剤製品概要 - タイプ別市場（経口、非経口） - アプリケーション別市場（骨巨細胞腫、高カルシウム血症、骨粗鬆症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の骨吸収阻害剤販売量予測2017-2028 - 世界の骨吸収阻害剤売上予測2017-2028 - 骨吸収阻害剤の地域別販売量 - 骨吸収阻害剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別骨吸収阻害剤販売量 - 主要メーカー別骨吸収阻害剤売上 - 主要メーカー別骨吸収阻害剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（経口、非経口） - 骨吸収阻害剤のタイプ別販売量 - 骨吸収阻害剤のタイプ別売上 - 骨吸収阻害剤のタイプ別価格 ・アプリケーション別市場規模（骨巨細胞腫、高カルシウム血症、骨粗鬆症、その他） - 骨吸収阻害剤のアプリケーション別販売量 - 骨吸収阻害剤のアプリケーション別売上 - 骨吸収阻害剤のアプリケーション別価格 ・北米市場 - 北米の骨吸収阻害剤市場規模（タイプ別、アプリケーション別） - 主要国別の骨吸収阻害剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの骨吸収阻害剤市場規模（タイプ別、アプリケーション別） - 主要国別の骨吸収阻害剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の骨吸収阻害剤市場規模（タイプ別、アプリケーション別） - 主要国別の骨吸収阻害剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の骨吸収阻害剤市場規模（タイプ別、アプリケーション別） - 主要国別の骨吸収阻害剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの骨吸収阻害剤市場規模（タイプ別、アプリケーション別） - 主要国別の骨吸収阻害剤市場規模（トルコ、サウジアラビア） ・企業情報 Novartis、Pfizer、Amgen、Apotex、Athenex Pharmaceuticl Divison、BPI Labs、Cipla USA、Merck、Mylan Institutional、Sagent Pharmaceuticals、Accord Healthcare、Fresenius Kabi、Dr. Reddy's Laboratories、Viatris、Hikma Pharmaceuticals、Aurobindo Pharma、Akorn、Teva Pharmaceuticals、Sun Pharma、Sun Pharmaceutical Industries ・産業チェーン及び販売チャネル分析 - 骨吸収阻害剤の産業チェーン分析 - 骨吸収阻害剤の原材料 - 骨吸収阻害剤の生産プロセス - 骨吸収阻害剤の販売及びマーケティング - 骨吸収阻害剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 骨吸収阻害剤の産業動向 - 骨吸収阻害剤のマーケットドライバー - 骨吸収阻害剤の課題 - 骨吸収阻害剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Bone Resorption Inhibitors estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Bone Resorption Inhibitors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Bone Resorption Inhibitors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Bone Resorption Inhibitors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Bone Resorption Inhibitors include Novartis, Pfizer, Amgen, Apotex, Athenex Pharmaceuticl Divison, BPI Labs, Cipla USA, Merck and Mylan Institutional, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bone Resorption Inhibitors companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Bone Resorption Inhibitors market. Further, it explains the major drivers and regional dynamics of the global Bone Resorption Inhibitors market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Novartis
Pfizer
Amgen
Apotex
Athenex Pharmaceuticl Divison
BPI Labs
Cipla USA
Merck
Mylan Institutional
Sagent Pharmaceuticals
Accord Healthcare
Fresenius Kabi
Dr. Reddy’s Laboratories
Viatris
Hikma Pharmaceuticals
Aurobindo Pharma
Akorn
Teva Pharmaceuticals
Sun Pharma
Sun Pharmaceutical Industries
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Bone Resorption Inhibitors Segment by Type
Oral
Parenteral
Bone Resorption Inhibitors Segment by Application
Giant Cell Tumor of Bone
Hypercalcemia
Osteoporosis
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Bone Resorption Inhibitors market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Bone Resorption Inhibitors market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Bone Resorption Inhibitors, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bone Resorption Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bone Resorption Inhibitors revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Bone Resorption Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Bone Resorption Inhibitors revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis, Pfizer, Amgen, Apotex, Athenex Pharmaceuticl Divison, BPI Labs, Cipla USA, Merck and Mylan Institutional, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Bone Resorption Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bone Resorption Inhibitors companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bone Resorption Inhibitors revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone Resorption Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Bone Resorption Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Giant Cell Tumor of Bone
1.3.3 Hypercalcemia
1.3.4 Osteoporosis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bone Resorption Inhibitors Market Perspective (2017-2028)
2.2 Bone Resorption Inhibitors Growth Trends by Region
2.2.1 Bone Resorption Inhibitors Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Bone Resorption Inhibitors Historic Market Size by Region (2017-2022)
2.2.3 Bone Resorption Inhibitors Forecasted Market Size by Region (2023-2028)
2.3 Bone Resorption Inhibitors Market Dynamics
2.3.1 Bone Resorption Inhibitors Industry Trends
2.3.2 Bone Resorption Inhibitors Market Drivers
2.3.3 Bone Resorption Inhibitors Market Challenges
2.3.4 Bone Resorption Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bone Resorption Inhibitors Players by Revenue
3.1.1 Global Top Bone Resorption Inhibitors Players by Revenue (2017-2022)
3.1.2 Global Bone Resorption Inhibitors Revenue Market Share by Players (2017-2022)
3.2 Global Bone Resorption Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bone Resorption Inhibitors Revenue
3.4 Global Bone Resorption Inhibitors Market Concentration Ratio
3.4.1 Global Bone Resorption Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone Resorption Inhibitors Revenue in 2021
3.5 Bone Resorption Inhibitors Key Players Head office and Area Served
3.6 Key Players Bone Resorption Inhibitors Product Solution and Service
3.7 Date of Enter into Bone Resorption Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bone Resorption Inhibitors Breakdown Data by Type
4.1 Global Bone Resorption Inhibitors Historic Market Size by Type (2017-2022)
4.2 Global Bone Resorption Inhibitors Forecasted Market Size by Type (2023-2028)
5 Bone Resorption Inhibitors Breakdown Data by Application
5.1 Global Bone Resorption Inhibitors Historic Market Size by Application (2017-2022)
5.2 Global Bone Resorption Inhibitors Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Bone Resorption Inhibitors Market Size (2017-2028)
6.2 North America Bone Resorption Inhibitors Market Size by Type
6.2.1 North America Bone Resorption Inhibitors Market Size by Type (2017-2022)
6.2.2 North America Bone Resorption Inhibitors Market Size by Type (2023-2028)
6.2.3 North America Bone Resorption Inhibitors Market Share by Type (2017-2028)
6.3 North America Bone Resorption Inhibitors Market Size by Application
6.3.1 North America Bone Resorption Inhibitors Market Size by Application (2017-2022)
6.3.2 North America Bone Resorption Inhibitors Market Size by Application (2023-2028)
6.3.3 North America Bone Resorption Inhibitors Market Share by Application (2017-2028)
6.4 North America Bone Resorption Inhibitors Market Size by Country
6.4.1 North America Bone Resorption Inhibitors Market Size by Country (2017-2022)
6.4.2 North America Bone Resorption Inhibitors Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bone Resorption Inhibitors Market Size (2017-2028)
7.2 Europe Bone Resorption Inhibitors Market Size by Type
7.2.1 Europe Bone Resorption Inhibitors Market Size by Type (2017-2022)
7.2.2 Europe Bone Resorption Inhibitors Market Size by Type (2023-2028)
7.2.3 Europe Bone Resorption Inhibitors Market Share by Type (2017-2028)
7.3 Europe Bone Resorption Inhibitors Market Size by Application
7.3.1 Europe Bone Resorption Inhibitors Market Size by Application (2017-2022)
7.3.2 Europe Bone Resorption Inhibitors Market Size by Application (2023-2028)
7.3.3 Europe Bone Resorption Inhibitors Market Share by Application (2017-2028)
7.4 Europe Bone Resorption Inhibitors Market Size by Country
7.4.1 Europe Bone Resorption Inhibitors Market Size by Country (2017-2022)
7.4.2 Europe Bone Resorption Inhibitors Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bone Resorption Inhibitors Market Size (2017-2028)
8.2 Asia-Pacific Bone Resorption Inhibitors Market Size by Type
8.2.1 Asia-Pacific Bone Resorption Inhibitors Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Bone Resorption Inhibitors Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Bone Resorption Inhibitors Market Share by Type (2017-2028)
8.3 Asia-Pacific Bone Resorption Inhibitors Market Size by Application
8.3.1 Asia-Pacific Bone Resorption Inhibitors Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Bone Resorption Inhibitors Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Bone Resorption Inhibitors Market Share by Application (2017-2028)
8.4 Asia-Pacific Bone Resorption Inhibitors Market Size by Region
8.4.1 Asia-Pacific Bone Resorption Inhibitors Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Bone Resorption Inhibitors Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bone Resorption Inhibitors Market Size (2017-2028)
9.2 Latin America Bone Resorption Inhibitors Market Size by Type
9.2.1 Latin America Bone Resorption Inhibitors Market Size by Type (2017-2022)
9.2.2 Latin America Bone Resorption Inhibitors Market Size by Type (2023-2028)
9.2.3 Latin America Bone Resorption Inhibitors Market Share by Type (2017-2028)
9.3 Latin America Bone Resorption Inhibitors Market Size by Application
9.3.1 Latin America Bone Resorption Inhibitors Market Size by Application (2017-2022)
9.3.2 Latin America Bone Resorption Inhibitors Market Size by Application (2023-2028)
9.3.3 Latin America Bone Resorption Inhibitors Market Share by Application (2017-2028)
9.4 Latin America Bone Resorption Inhibitors Market Size by Country
9.4.1 Latin America Bone Resorption Inhibitors Market Size by Country (2017-2022)
9.4.2 Latin America Bone Resorption Inhibitors Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bone Resorption Inhibitors Market Size (2017-2028)
10.2 Middle East & Africa Bone Resorption Inhibitors Market Size by Type
10.2.1 Middle East & Africa Bone Resorption Inhibitors Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Bone Resorption Inhibitors Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Bone Resorption Inhibitors Market Share by Type (2017-2028)
10.3 Middle East & Africa Bone Resorption Inhibitors Market Size by Application
10.3.1 Middle East & Africa Bone Resorption Inhibitors Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Bone Resorption Inhibitors Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Bone Resorption Inhibitors Market Share by Application (2017-2028)
10.4 Middle East & Africa Bone Resorption Inhibitors Market Size by Country
10.4.1 Middle East & Africa Bone Resorption Inhibitors Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Bone Resorption Inhibitors Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Bone Resorption Inhibitors Introduction
11.1.4 Novartis Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Bone Resorption Inhibitors Introduction
11.2.4 Pfizer Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Bone Resorption Inhibitors Introduction
11.3.4 Amgen Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.3.5 Amgen Recent Developments
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Apotex Business Overview
11.4.3 Apotex Bone Resorption Inhibitors Introduction
11.4.4 Apotex Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.4.5 Apotex Recent Developments
11.5 Athenex Pharmaceuticl Divison
11.5.1 Athenex Pharmaceuticl Divison Company Details
11.5.2 Athenex Pharmaceuticl Divison Business Overview
11.5.3 Athenex Pharmaceuticl Divison Bone Resorption Inhibitors Introduction
11.5.4 Athenex Pharmaceuticl Divison Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.5.5 Athenex Pharmaceuticl Divison Recent Developments
11.6 BPI Labs
11.6.1 BPI Labs Company Details
11.6.2 BPI Labs Business Overview
11.6.3 BPI Labs Bone Resorption Inhibitors Introduction
11.6.4 BPI Labs Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.6.5 BPI Labs Recent Developments
11.7 Cipla USA
11.7.1 Cipla USA Company Details
11.7.2 Cipla USA Business Overview
11.7.3 Cipla USA Bone Resorption Inhibitors Introduction
11.7.4 Cipla USA Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.7.5 Cipla USA Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Bone Resorption Inhibitors Introduction
11.8.4 Merck Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Mylan Institutional
11.9.1 Mylan Institutional Company Details
11.9.2 Mylan Institutional Business Overview
11.9.3 Mylan Institutional Bone Resorption Inhibitors Introduction
11.9.4 Mylan Institutional Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.9.5 Mylan Institutional Recent Developments
11.10 Sagent Pharmaceuticals
11.10.1 Sagent Pharmaceuticals Company Details
11.10.2 Sagent Pharmaceuticals Business Overview
11.10.3 Sagent Pharmaceuticals Bone Resorption Inhibitors Introduction
11.10.4 Sagent Pharmaceuticals Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.10.5 Sagent Pharmaceuticals Recent Developments
11.11 Accord Healthcare
11.11.1 Accord Healthcare Company Details
11.11.2 Accord Healthcare Business Overview
11.11.3 Accord Healthcare Bone Resorption Inhibitors Introduction
11.11.4 Accord Healthcare Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.11.5 Accord Healthcare Recent Developments
11.12 Fresenius Kabi
11.12.1 Fresenius Kabi Company Details
11.12.2 Fresenius Kabi Business Overview
11.12.3 Fresenius Kabi Bone Resorption Inhibitors Introduction
11.12.4 Fresenius Kabi Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.12.5 Fresenius Kabi Recent Developments
11.13 Dr. Reddy’s Laboratories
11.13.1 Dr. Reddy’s Laboratories Company Details
11.13.2 Dr. Reddy’s Laboratories Business Overview
11.13.3 Dr. Reddy’s Laboratories Bone Resorption Inhibitors Introduction
11.13.4 Dr. Reddy’s Laboratories Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.13.5 Dr. Reddy’s Laboratories Recent Developments
11.14 Viatris
11.14.1 Viatris Company Details
11.14.2 Viatris Business Overview
11.14.3 Viatris Bone Resorption Inhibitors Introduction
11.14.4 Viatris Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.14.5 Viatris Recent Developments
11.15 Hikma Pharmaceuticals
11.15.1 Hikma Pharmaceuticals Company Details
11.15.2 Hikma Pharmaceuticals Business Overview
11.15.3 Hikma Pharmaceuticals Bone Resorption Inhibitors Introduction
11.15.4 Hikma Pharmaceuticals Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.15.5 Hikma Pharmaceuticals Recent Developments
11.16 Aurobindo Pharma
11.16.1 Aurobindo Pharma Company Details
11.16.2 Aurobindo Pharma Business Overview
11.16.3 Aurobindo Pharma Bone Resorption Inhibitors Introduction
11.16.4 Aurobindo Pharma Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.16.5 Aurobindo Pharma Recent Developments
11.17 Akorn
11.17.1 Akorn Company Details
11.17.2 Akorn Business Overview
11.17.3 Akorn Bone Resorption Inhibitors Introduction
11.17.4 Akorn Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.17.5 Akorn Recent Developments
11.18 Teva Pharmaceuticals
11.18.1 Teva Pharmaceuticals Company Details
11.18.2 Teva Pharmaceuticals Business Overview
11.18.3 Teva Pharmaceuticals Bone Resorption Inhibitors Introduction
11.18.4 Teva Pharmaceuticals Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.18.5 Teva Pharmaceuticals Recent Developments
11.19 Sun Pharma
11.19.1 Sun Pharma Company Details
11.19.2 Sun Pharma Business Overview
11.19.3 Sun Pharma Bone Resorption Inhibitors Introduction
11.19.4 Sun Pharma Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.19.5 Sun Pharma Recent Developments
11.20 Sun Pharmaceutical Industries
11.20.1 Sun Pharmaceutical Industries Company Details
11.20.2 Sun Pharmaceutical Industries Business Overview
11.20.3 Sun Pharmaceutical Industries Bone Resorption Inhibitors Introduction
11.20.4 Sun Pharmaceutical Industries Revenue in Bone Resorption Inhibitors Business (2017-2022)
11.20.5 Sun Pharmaceutical Industries Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer